> ## Content Index
> Fetch the complete content index at: https://www.scar-healing.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Evidence-Based Guide to Steroid Injections for Surgical and C-Section Scars
- URL: https://www.scar-healing.com/steroid-injections-for-surgical-and-c-section-scars/
- Published: 2026-08-22T21:16:14.000Z
- Updated: 2026-08-22T21:38:07.000Z
- Description: Raised surgical and caesarean scars respond well to intralesional steroid injections, but timing and dose matter more than most patients are told. Here is what the evidence supports.
- Author: The Scar Healing Editorial Team
- Tags: Surgical Scars, C-Section Scars, Scar Treatment, Professional Treatment, Corticosteroid Injections

## When steroid injections are used

**Steroid injections for surgical and C-section scars may help flatten, soften, and reduce itch or pain in raised scars.** They are most often used for hypertrophic scars, which stay within the original incision line, and keloids, which grow beyond it. A dermatologist, plastic surgeon, or qualified scar specialist injects corticosteroid medicine directly into the scar tissue, usually in a series of treatments spaced about four weeks apart.

Evidence suggests that intralesional triamcinolone, a commonly used corticosteroid, reduces inflammation, slows overactive fibroblasts (the cells that produce collagen), and supports collagen remodeling. It is not designed to erase a flat, pale scar or treat an open, infected, or poorly healed incision.

For C-section keloids that need surgical removal, research indicates that adding steroid treatment at or after excision may lower recurrence compared with excision alone, although results vary by scar type, injection protocol, and follow-up time. A 2025 clinical study of repeat C-sections reported substantially lower recurrence after excision plus subdermal triamcinolone than after excision alone, but this approach should be planned individually with the surgical and obstetric team.

This guide from **The Scar Healing Editorial Team** explains who may benefit, what treatment involves, and how injections fit into a safe scar-care plan.

## How steroid injections change a scar

When an incision penetrates the reticular dermis—the thick, fibrous lower layer of the skin—the body initiates an intricate healing cascade: hemostasis, inflammation, proliferation, and tissue remodeling. In typical wound repair, this progression results in a mature, flat scar. In pathological scarring, however, localized chronic inflammation drives dermal fibroblasts to continuously produce excess extracellular matrix and collagen bundles.

![diagram of corticosteroid mechanism suppressing fibroblasts and collagen in scar tissue](https://storage.googleapis.com/ai-templates.appspot.com/temp_images/fe4eefd3a96c4ff6b9839396a815f879.png "diagram of corticosteroid mechanism suppressing fibroblasts and collagen in scar tissue")

Corticosteroids exert potent anti-inflammatory and vasoconstrictive effects on pathologically active tissue. When injected intralesionally, the medication binds to intracellular glucocorticoid receptors, triggering altered gene transcription that dampens the inflammatory response. Local vasoconstriction diminishes capillary blood flow, which starves the metabolically demanding tissue of oxygen and nutrients. This physiological shift often causes visible, immediate blanching of the scar tissue during the procedure. According to a [clinical study on triamcinolone acetonide in scar maturation](https://journals.lww.com/prsgo/fulltext/2024/07000/role%5Fof%5Ftriamcinolone%5Facetonide%5Fin%5Fthe%5Fmaturation.35.aspx?ref=scar-healing.com), local infiltration of low-dose triamcinolone acetonide along incision lines significantly improves objective parameters such as vascularity, pigmentation, and overall aesthetic maturation over a 12-month evaluation period.

### What happens in the tissue

At the cellular level, corticosteroids target the key drivers of fibrotic disease:

- **Inhibition of Pro-inflammatory Mediators:** Corticosteroid molecules downregulate critical transcription factors, including nuclear factor kappa B (NF-$\\kappa$B) and activator protein 1 (AP-1), significantly decreasing the production of pro-inflammatory cytokines such as interleukin-1 (IL-1) and interleukin-6 (IL-6).
- **Suppression of Transforming Growth Factor-Beta (TGF-$\\beta$):** Fibroblast hyperactivity is largely mediated by TGF-$\\beta$ isoforms (specifically TGF-$\\beta$1 and TGF-$\\beta$2). Corticosteroids retard the expression of these cytokines, slowing cellular proliferation and halting uncontrolled collagen synthesis.
- **Vascular Endothelial Growth Factor (VEGF) Downregulation:** By reducing VEGF levels, corticosteroids suppress the formation of abnormal microvessels, resolving persistent erythema (redness).
- **Collagenase Activation and Bundle Degradation:** Glucocorticoids reduce the concentration of alpha-1-antitrypsin and alpha-2-macroglobulin (natural inhibitors of collagenase). This enzymatic release enhances endogenous collagenase activity, enabling the body to break down dense, disorganized collagen bundles into more pliable tissue structures.

### Which scars respond best

Pathological scars are generally categorized into two primary forms, both of which serve as primary indications for intralesional therapy:

1. **Hypertrophic Scars:** These lesions present as raised, firm, erythematous bands that remain strictly confined within the boundaries of the original surgical incision. They commonly arise within 4 to 8 weeks post-surgery due to wound tension or prolonged inflammation, often demonstrating rapid initial growth before plateauing.
2. **Keloid Scars:** Keloids represent an aggressive fibroproliferative disorder where scar tissue extends beyond the initial margins of the wound, invading adjacent healthy dermis. Keloid scars affect an estimated 10% to 15% of all wounds and exhibit higher prevalence in individuals with darker skin tones (Fitzpatrick skin types IV–VI), who demonstrate an estimated 15- to 20-fold increased risk.

For patients managing raised, itchy, or painful [surgical scars](https://www.scar-healing.com/scar-types/surgical/) or thick, restrictive [c-section scars](https://www.scar-healing.com/scar-types/csection/), intralesional injections provide a targeted method for [abdomen keloid scar reduction](https://www.scar-healing.com/abdomen-keloid-scar-reduction/). By dampening reticular dermal inflammation and disrupting pathological innervation, steroid injections frequently alleviate the persistent pruritus (itching) and physical tenderness that accompany active scar remodeling.

## Dosing, timing and technique

![dermatologist administering intralesional steroid injection with a fine gauge needle](https://images.bannerbear.com/direct/4mGpW3zwpg0ZK0AxQw/requests/000/159/083/573/nyLXxdvaNQg3aep5Q9wePZm1E/772424186ba6dcdcc224a685190f930b4e27b6ce.jpg "dermatologist administering intralesional steroid injection with a fine gauge needle")

Successful scar modulation requires precise clinical execution. Corticosteroids are administered directly into the substance of the scar rather than into surrounding tissues, utilizing strict clinical protocols to maximize tissue remodeling while minimizing adverse local reactions. As detailed in a [systematic review on post-surgical corticosteroid safety and timing](https://pmc.ncbi.nlm.nih.gov/articles/PMC9042756/?ref=scar-healing.com), the timing of postoperative corticosteroid administration must balance therapeutic tissue modulation with safety, as premature intervention can elevate surgical site complication risks.

### When to start treatment

Determining [when to start scar treatment after surgery](https://www.scar-healing.com/when-to-start-scar-treatment-after-surgery/) depends on wound epithelialization and tissue maturity:

- **Immediate Postoperative Phase (Weeks 0–2):** Steroid injections are avoided in healing wounds during this early phase. Premature administration can compromise wound tensile strength, inhibit natural re-epithelialization, and increase the odds of wound dehiscence or infection.
- **Early Proliferative Phase (Weeks 4–8):** Once sutures are removed, the incision is fully closed, and the initial epithelial barrier is intact, early signs of abnormal hypertrophy (such as thickening, worsening erythema, or unrelenting itch) may be evaluated by a physician for conservative, low-dose intralesional therapy.
- **Mature Phase (Months 6–12+):** Scars naturally remodel over 12 to 18 months. Mature, dense hypertrophic scars and established keloids often require structured serial injection protocols to induce collagen breakdown and tissue softening.

### How the injection is given

Triamcinolone acetonide (TAC) represents the standard agent for intralesional therapy:

- **Concentration Ranges:** Typical concentrations range from 2.5 mg/mL to 40 mg/mL, depending on anatomical location, scar thickness, and patient skin type. For linear surgical incisions and delicate abdominal skin, clinicians frequently initiate therapy at lower concentrations (2.5 mg/mL to 10 mg/mL), reserving higher concentrations (20 mg/mL to 40 mg/mL) for dense, recalcitrant keloids.
- **Needle Gauge and Equipment:** Injections are delivered using high-gauge, fine-bore needles—typically 27-gauge to 30-gauge—attached to Luer-lock syringes to withstand the high injection resistance encountered within dense fibrous tissue.
- **Depth and Placement:** The needle is advanced strictly into the mid-to-upper reticular dermis of the scar. Resistance must be felt during injection; if the medication flows without resistance, the needle tip has likely entered the subcutaneous fat plane. Infiltrating corticosteroids into the subcutaneous adipose layer must be strictly avoided, as it can cause significant localized lipoatrophy (fat loss) and visible skin indentations.
- **Dosing Volume:** In linear scars, approximately 0.05 mL to 0.1 mL is infiltrated per 5 to 8 mm segment of tissue until subtle blanching is observed, ensuring the steroid suspension remains uniformly distributed without tissue over-distension.

## How well it works, alone and combined

While intralesional triamcinolone monotherapy eventually achieves flattening in 50% to 100% of treated hypertrophic and keloid scars, clinical recurrence rates with single-agent therapy range from 9% to 50%. To enhance efficacy and reduce recurrence, clinicians frequently integrate multimodal regimens, utilizing [keloid treatment without surgery](https://www.scar-healing.com/keloid-treatment-without-surgery/) to optimize outcomes.

![diagram of multimodal scar treatment matrix combining steroids lasers and antimetabolites](https://storage.googleapis.com/ai-templates.appspot.com/temp_images/51ab1d6ec518480ba0d2a039b29d1395.png "diagram of multimodal scar treatment matrix combining steroids lasers and antimetabolites")

- **Corticosteroids Combined with 5-Fluorouracil (5-FU):** 5-FU is a pyrimidine analog that inhibits thymidylate synthase, arresting fibroblast proliferation and collagen production. Combining triamcinolone (e.g., 10 mg/mL) with 5-FU (e.g., 50 mg/mL in a 1:9 or 2:8 ratio) demonstrates superior scar flattening with significantly lower rates of steroid-induced skin atrophy and telangiectasia compared to high-dose steroid monotherapy alone.
- **Pulsed Dye Laser (PDL) and Vascular Lasers:** Vascular lasers (such as the 595 nm PDL) selectively target oxyhemoglobin within the microvasculature supplying the scar, causing selective photothermolysis. Combining PDL with intralesional steroids addresses both tissue height and chronic erythema simultaneously.
- **Fractional Carbon Dioxide ($CO\_2$) Laser-Assisted Delivery:** Fractional ablative lasers create microscopic thermal zones throughout dense keloid tissue, facilitating deeper, uniform percutaneous absorption of topically applied corticosteroid suspensions.

### Steroid injection during scar surgery

Surgical removal of keloid tissue alone is associated with a 50% to 100% recurrence rate, often resulting in a recurrent lesion larger than the original scar due to re-triggered reticular inflammation. Consequently, surgical revision must be paired with adjuvant suppression.

For patients pursuing [c-section scar revision](https://www.scar-healing.com/c-section-scar-revision/), intraoperative corticosteroid infiltration at the time of wound closure provides a substantial reduction in recurrence. According to a [clinical trial on intraoperative triamcinolone for cesarean keloids](https://doi.org/10.21608/ejhm.2025.449950?ref=scar-healing.com), combining surgical excision with immediate subdermal triamcinolone acetonide infiltration along the wound edges reduced keloid recurrence from 91.4% (in the excision-alone cohort) to 22.58% ($P < 0.001$). Standardized protocols documented in a [trial registration for caesarean section keloid steroid injection](https://anzctr.org.au/ACTRN12618000984291.aspx?ref=scar-healing.com) utilize a total intraoperative dose of 20 mg triamcinolone acetonide (10 mg infiltrated into the superior wound margin and 10 mg into the inferior margin using a 25-gauge needle) prior to layered, tension-free dermal closure.

### How it compares with other treatments

Managing complex surgical incisions, such as a [keloid tummy tuck scar](https://www.scar-healing.com/keloid-tummy-tuck-scar/) or wide post-operative abdominal bands, requires choosing the appropriate modality based on scar maturity, tissue volume, and clinical goals:

| Treatment Modality                        | Primary Mechanism                                                          | Best Suited For                                                | Advantages                                                                        | Limitations / Considerations                                                                 |
| ----------------------------------------- | -------------------------------------------------------------------------- | -------------------------------------------------------------- | --------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------- |
| **Intralesional Steroid Injections**      | Suppresses fibroblast activity; halts collagen synthesis; degrades matrix. | Raised, firm, itchy hypertrophic scars and keloids.            | Highly effective for flattening thickness and relieving pain/pruritus.            | Does not narrow scar width; potential for localized atrophy or telangiectasia.               |
| **Medical-Grade Silicone Gel / Sheeting** | Increases stratum corneum hydration; normalizes growth factor signaling.   | Early post-surgical scars; prophylaxis on closed incisions.    | Non-invasive; zero downtime; suitable for sensitive skin and home use.            | Requires consistent daily wear (12–24 hrs/day) over 3–6 months for optimal effect.           |
| **Vascular Laser Therapy (PDL / 595 nm)** | Selective photothermolysis of microvessels feeding scar tissue.            | Erythematous, vascular, actively proliferating immature scars. | Reduces redness and decreases blood supply without needle trauma.                 | Multiple sessions required; higher cost; less effective as monotherapy for thick keloids.    |
| **Surgical Scar Revision**                | Complete excision of fibrous tissue followed by layered closure.           | Wide, tethered, contracted, or mechanically distorted scars.   | Resets wound margins; allows mechanical re-alignment along relaxed tension lines. | Carries 50–100% keloid recurrence risk if performed without adjuvant therapy (steroids/PDL). |

## Side effects and aftercare

While intralesional corticosteroid administration is an established, minimally invasive procedure, improper dosing, incorrect injection depth, or excessive volume can cause localized and systemic side effects.

### What can go wrong

- **Dermal and Subcutaneous Atrophy:** Over-concentration or accidental deposition into the subcutaneous fat layer causes localized loss of adipose tissue and dermal thinning, resulting in a visible depression or dimple. Titrating concentrations to the minimum effective dose (often 2.5 to 10 mg/mL initially) and ensuring strict intradermal needle placement mitigates this risk.
- **Telangiectasia:** Corticosteroids can stimulate superficial microvascular dilation, causing fine, visible spider veins on or surrounding the scar. Vascular laser therapy can be utilized if telangiectasias develop.
- **Pigmentary Alterations:** Both hypopigmentation (lightening of the skin) and hyperpigmentation can occur. Patients with darker skin phototypes (Fitzpatrick IV–VI) are particularly vulnerable to melanocyte suppression. Diluting the corticosteroid suspension and extending treatment intervals helps protect epidermal melanocytes.
- **Systemic Absorption:** Although rare with low-volume intralesional therapy, high cumulative doses can cause transient systemic glucocorticoid absorption, potentially impacting blood glucose control in diabetic patients or causing temporary menstrual irregularities.

### Caring for your scar afterwards

Adhering to a structured aftercare plan supports tissue remodeling and minimizes adverse events:

- **Post-Injection Massage:** Gentle scar massage for 24 hours following the procedure helps distribute the micronized steroid crystals uniformly throughout the fibrous matrix.
- **Sun Protection:** Healing and newly injected scar tissue must be strictly protected from ultraviolet (UV) radiation using broad-spectrum sunscreen (SPF 30+) or physical clothing to prevent UV-induced hyperpigmentation.
- **Adjunctive Compression:** Applying medical-grade silicone sheets or wearing supportive, high-waisted compression garments over the abdominal area reduces mechanical skin tension, promoting smoother contour alignment.
- **Activity Restrictions:** Patients should avoid heavy abdominal lifting or high-intensity strain for 24 to 48 hours following injection to avoid localized hematoma formation or tissue irritation.

## Common questions

### How many steroid injection sessions are typically needed to flatten a scar?

Most hypertrophic and keloid scars require a series of 3 to 6 injection sessions spaced approximately 4 to 6 weeks apart. Scars with extensive collagen density or large surface area may require additional maintenance sessions. Treatment is typically paused once the scar has flattened to skin level to avoid inducing tissue depression.

### Are intralesional steroid injections safe while breastfeeding?

Clinical evidence indicates that localized intralesional triamcinolone injections present minimal risk during lactation. Because the medication is administered directly into the scar tissue in small volumes (typically 10 to 20 mg total), systemic bioavailability is extremely low, resulting in negligible transfer into maternal breast milk. Postpartum patients should review their specific medical profile with their obstetrician or dermatologist.

### Are steroid injections for post-surgical scars covered by insurance?

Coverage depends on whether the procedure is deemed medically necessary or elective/cosmetic. When intralesional injections are administered to treat chronic pain, unrelenting pruritus, severe contracture, or functional mobility restrictions caused by hypertrophic or keloid scarring, many health insurance plans provide coverage with appropriate clinical documentation. Injections performed purely to refine the visual appearance of a flat, asymptomatic scar are generally classified as elective cosmetic procedures.

## What this means for your scar

Intralesional corticosteroid injections remain a foundational, evidence-based modality for managing raised, painful, or hypertrophic surgical and C-section scars. By suppressing overactive fibroblast proliferation, downregulating pro-inflammatory cytokines, and promoting the enzymatic breakdown of excessive collagen bundles, targeted steroid therapy effectively softens and flattens thickened scar tissue. For optimal aesthetic and functional outcomes, treatment should be tailored to scar maturity, individual skin type, and integrated with comprehensive [post-surgery scar care](https://www.scar-healing.com/post-surgery-scar-care/).

This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for diagnosis and treatment.

## Works Cited

1. Abdel-Hamid AM, et al. “[Effect of surgical excision and subdermal injection of triamcinolone acetonide for treatment of keloid scars after cesarean section](https://doi.org/10.21608/ejhm.2025.449950?ref=scar-healing.com).” *The Egyptian Journal of Hospital Medicine*, 2025.
2. Bhosale R, Dawar R, Manas RK. “[Role of triamcinolone acetonide in the maturation of scars](https://pubmed.ncbi.nlm.nih.gov/39015354/?ref=scar-healing.com).” *Plastic and Reconstructive Surgery – Global Open*, 2024.
3. Brezeanu AM, Brezeanu D, Tica VI. “[Intraoperative platelet-rich plasma (PRP) for post-cesarean scar healing: a single-center randomized controlled pilot study](https://pubmed.ncbi.nlm.nih.gov/41302316/?ref=scar-healing.com).” *Healthcare (Basel)*, 2025.
4. Chua SC, Gidaszewski B, Khajehei M. “[Efficacy of surgical excision and sub-dermal injection of triamcinolone acetonide for treatment of keloid scars after caesarean section: a single blind randomised controlled trial protocol](https://pubmed.ncbi.nlm.nih.gov/31215471/?ref=scar-healing.com).” *Trials*, 2019.
5. Lee J, Kim J. “[Minimal-invasive technologies for treatment of HTS and keloids: corticosteroids](https://www.ncbi.nlm.nih.gov/books/NBK586094/?ref=scar-healing.com).” *Textbook on Scar Management, Springer*, 2020.
6. Puzzitiello RN, Patel BH, Lavoie-Gagne O, et al. “[Corticosteroid injections after rotator cuff repair improve function, reduce pain, and are safe: a systematic review](https://pubmed.ncbi.nlm.nih.gov/35494258/?ref=scar-healing.com).” *Arthroscopy, Sports Medicine, and Rehabilitation*, 2022.
7. Tullington JE, Gemma R. “[Scar revision](https://www.ncbi.nlm.nih.gov/books/NBK542318/?ref=scar-healing.com).” *StatPearls, NCBI Bookshelf*, 2026.